BOTOX® vs. XEOMIN® for Chronic Migraine — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

BOTOX® vs. XEOMIN® for Chronic Migraine — Stella

Recruiting

Back to Chronic Migraine trials

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(1 site)

United States

Naval Medical Center Camp Lejeune, Jacksonville, North Carolina

Key details

Phase

Large-scale testing

Sponsor

Naval Medical Center Camp Lejeune

Enrollment target

~128 participants

Started

February 2023

Primary completion

February 2026

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years – 89 Years

Last updated May 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov